[PDF][PDF] GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells

M Greter, J Helft, A Chow, D Hashimoto, A Mortha… - Immunity, 2012 - cell.com
M Greter, J Helft, A Chow, D Hashimoto, A Mortha, J Agudo-Cantero, M Bogunovic…
Immunity, 2012cell.com
Summary GM-CSF (Csf-2) is a critical cytokine for the in vitro generation of dendritic cells
(DCs) and is thought to control the development of inflammatory DCs and resident CD103+
DCs in some tissues. Here we showed that in contrast to the current understanding, Csf-2
receptor acts in the steady state to promote the survival and homeostasis of nonlymphoid
tissue-resident CD103+ and CD11b+ DCs. Absence of Csf-2 receptor on lung DCs
abrogated the induction of CD8+ T cell immunity after immunization with particulate …
Summary
GM-CSF (Csf-2) is a critical cytokine for the in vitro generation of dendritic cells (DCs) and is thought to control the development of inflammatory DCs and resident CD103+ DCs in some tissues. Here we showed that in contrast to the current understanding, Csf-2 receptor acts in the steady state to promote the survival and homeostasis of nonlymphoid tissue-resident CD103+ and CD11b+ DCs. Absence of Csf-2 receptor on lung DCs abrogated the induction of CD8+ T cell immunity after immunization with particulate antigens. In contrast, Csf-2 receptor was dispensable for the differentiation and innate function of inflammatory DCs during acute injuries. Instead, inflammatory DCs required Csf-1 receptor for their development. Thus, Csf-2 is important in vaccine-induced CD8+ T cell immunity through the regulation of nonlymphoid tissue DC homeostasis rather than control of inflammatory DCs in vivo.
cell.com